semaglutide for heart patients In with cardiometabolic #HFpEF, #semaglutide and #tirzepatide reduced the risk of hospitalization failure or all-cause mortality vs sitagliptin, but tirzepatide offered no additional benefit over semaglutide. https://ja.ma/3JO2SQc Semaglutide Cuts Heart Risk Beyond

If you are allergic to a certain ingredient in FDA-approved semaglutide, you can get custom-made compounded semaglutide without that allergen

In chronic weight management, GLP-1 medications are sometimes used in conjunction with a low-calorie diet and increased physical activity

Receptor target Cyclic heptapeptide agonist of MC3R and MC4R

Clinicians must adopt a vigilant approach, involving regular monitoring of hematological parameters and cardiovascular signs and symptoms, to promptly address any adverse trends

Theoretically, a GLP-1 patch would be able to dispense medication gradually while reducing some of the side effects that the drugs are known for